Trials / Completed
CompletedNCT02896985
Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )
A Cohort Study to Evaluate the Effectiveness of Drug Concentrations in Predicting Recapture of Response With Weekly ADAlimumab in Crohn's Disease Subjects With Secondary Loss of Response (PRADA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center study that explores the relationship between recapture of response with escalation to weekly adalimumab and trough adalimumab concentration before escalation in patients experiencing lack of response (LOR).
Conditions
Timeline
- Start date
- 2016-12-16
- Primary completion
- 2020-03-11
- Completion
- 2020-03-11
- First posted
- 2016-09-12
- Last updated
- 2021-03-09
Locations
24 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02896985. Inclusion in this directory is not an endorsement.